Oruka Therapeutics (ORKA) Operating Leases (2020 - 2026)
Oruka Therapeutics (ORKA) posted quarterly Operating Leases of $1.1 million for Q1 2026, up 69.73% year-over-year from $664000.0 in Q1 2025, and down 14.17% quarter-over-quarter from $1.3 million in Q4 2025.
Oruka Therapeutics (ORKA) Operating Leases (2020 - 2026) Analysis & Trends
Oruka Therapeutics' Operating Leases history runs 7 years deep, the most recent figure standing at $1.1 million for Q1 2026.
- In Q1 2026, Operating Leases rose 69.73% year-over-year to $1.1 million; the TTM figure through Mar 2026 stood at $1.1 million (up 69.73% YoY), while the FY2025 annual figure was $1.3 million, up 73.91% from the prior year.
- Operating Leases for Q1 2026 stood at $1.1 million, down from $1.3 million in the prior quarter.
- The five-year high for Operating Leases was $1.7 million in Q2 2025, with the low at $24000.0 in Q2 2024.
- The 5-year median for Operating Leases is $447500.0 (2022), against an average of $655437.5.
- The sharpest annual moves came in 2024 and 2025: Operating Leases slumped 92.71% in 2024, then jumped 6841.67% in 2025.
- Oruka Therapeutics' Operating Leases stood at $280000.0 in 2022, then declined by 27.14% to $204000.0 in 2023, then surged by 270.1% to $755000.0 in 2024, then surged by 73.91% to $1.3 million in 2025, then retreated by 14.17% to $1.1 million in 2026.
- Business Quant data shows ORKA's Operating Leases at $1.1 million in Q1 2026, $1.3 million in Q4 2025, and $1.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Oruka Therapeutics | 6.98 Bn | 5.25 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.88 Mn |
| Mar 31, 2026 | 1.13 Mn |
| Dec 31, 2025 | 1.31 Mn |
| Sep 30, 2025 | 1.49 Mn |
| Jun 30, 2025 | 1.67 Mn |
| Mar 31, 2025 | 664,000.00 |
| Dec 31, 2024 | 755,000.00 |
| Sep 30, 2024 | 842,000.00 |
| Jun 30, 2024 | 24,000.00 |
| Dec 31, 2023 | 204,000.00 |
| Sep 30, 2023 | 224,000.00 |
| Jun 30, 2023 | 329,000.00 |
| Mar 31, 2023 | 262,000.00 |
| Dec 31, 2022 | 280,000.00 |
| Sep 30, 2022 | 409,000.00 |
| Jun 30, 2022 | 435,000.00 |
| Mar 31, 2022 | 460,000.00 |
| Dec 31, 2021 | 383,000.00 |
| Sep 30, 2021 | 410,000.00 |
| Jun 30, 2021 | 435,000.00 |